Ireland· IE-PA-PA1122/040/001
Ziremilon 200 mg/ml emulsion for infusion
A fettemulsionen product containing refined olive oil + fish oil, rich in omega-3 acids + refined soyabean oil + medium chain triglycerides, registered in Ireland by Noridem Enterprises Limited. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Fettemulsionen is registered in 11 of 19 countries.
Countries holding a registration under ATC B05BA02 (fettemulsionen), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Fettemulsionen · ATC B05BA02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Refined olive oil + Fish oil, rich in omega-3 acids + Refined soyabean oil + Medium chain triglycerides
- Manufacturer
- Noridem Enterprises Limited
- Country
- Ireland (IE)
- ATC code
- B05BA02
- ATC class
- Fettemulsionen
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1122/040/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05BA02
Fettemulsionen, as other registers publish it.
- FinlandClinoleicBaxter Oy
- DenmarkClinoleicBaxter A/S
- NorwayClinoleicBaxter Medical AB
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b0bab402-f96f-4442-b5bd-37b6deb3e86f GET /v1/drugs/b0bab402-f96f-4442-b5bd-37b6deb3e86f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Emulsion for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"B05BA02"
],
"strength": null,
"pa_number": "PA1122/040/001",
"substances": [
"Refined olive oil",
"Fish oil, rich in omega-3 acids",
"Refined soyabean oil",
"Medium chain triglycerides"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "12/09/2025",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about fettemulsionen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.